Egis Pharmaceuticals Overview

  • Founded
  • 1913
  • Status
  • Acquired/​Merged
  • Employees
  • 1,001
  • Latest Deal Type
  • Corporate
  • Financing Rounds
  • 2
  • Investments
  • 2

Egis Pharmaceuticals General Information


Manufacturer of pharmaceutical products. The company offers injections and galenic products in Central and Eastern Europe.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Medical Supplies
Other Industries
Drug Delivery
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • 10 Pf. 100
  • Budapest, 1475
  • Hungary
+36 (06 0) 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Egis Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Egis Pharmaceuticals‘s full profile, request access.

Request a free trial

Egis Pharmaceuticals Executive Team (5)

Name Title Board Seat Contact Info
István Hodász Chief Executive Officer
Csaba Poroszlai Chief Financial Officer
Tamás Ritter Managing Director
Zsolt Fehérdi Technical Director
You’re viewing 4 of 5 executive team members. Get the full list »

Egis Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Egis Pharmaceuticals Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000-00000000 00 02-Jun-2017 000000000 00000 00 Buildings and Property
Medimpex Hungary Merger/Acquisition Media and Information Services (B2B)
To view Egis Pharmaceuticals’s complete investments and acquisitions history, request access »